000 | 01957 a2200553 4500 | ||
---|---|---|---|
005 | 20250516003138.0 | ||
264 | 0 | _c20101019 | |
008 | 201010s 0 0 eng d | ||
022 | _a1558-3597 | ||
024 | 7 |
_a10.1016/j.jacc.2010.06.015 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRosenson, Robert S | |
245 | 0 | 0 |
_aEffects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. _h[electronic resource] |
260 |
_bJournal of the American College of Cardiology _cSep 2010 |
||
300 |
_a1079-88 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAcetates _xadministration & dosage |
650 | 0 | 4 |
_aAcute Coronary Syndrome _xdiagnosis |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAtorvastatin |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
650 | 0 | 4 |
_aCholesterol, LDL _xanalysis |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHeptanoic Acids _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xadministration & dosage |
650 | 0 | 4 | _aKeto Acids |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPhospholipases A2, Secretory _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHislop, Colin | |
700 | 1 | _aElliott, Michael | |
700 | 1 | _aStasiv, Yuri | |
700 | 1 | _aGoulder, Michael | |
700 | 1 | _aWaters, David | |
773 | 0 |
_tJournal of the American College of Cardiology _gvol. 56 _gno. 14 _gp. 1079-88 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacc.2010.06.015 _zAvailable from publisher's website |
999 |
_c20193843 _d20193843 |